AbbeyMoor to start prostatic stent trial:
This article was originally published in Clinica
Executive Summary
AbbeyMoor Medical is to begin US FDA clinical trials to assess its Spanner temporary prostatic stent for improving voiding and the quality of life in men suffering from severe lower urinary tract symptoms. The trials will enrol over 100 men and are expected to be completed by the end of the year, said the privately held Miltona, Minnesota company.